Samsara BioCapital, L.P. 13D/13G Filings for

Samsara BioCapital, L.P. 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-03-25
7:40 pm
Purchase
2025-03-18 13D AlloVir, Inc.
ALVR
Samsara BioCapital, L.P. 11,448,081
61.200%
11,448,081increase
(New Position)
Filing